CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
Conference
"Nouvelles lignes directrices pour la prophylaxie post-exposition (PPE)" Dr. Pierre Thibodeau (biography) French - 2002-11-29 - 30 minutes
(41 slides)
Summary : Des images qui ne manquent pas d’humour ! Dr Pierre Thibodeau présente de manière originale deux situations qui méritent sérieux et attention : celles des couples discordants désirant un enfant d’une part, et celle de la prophylaxie post-exposition d’autre part. Dr Thibodeau aborde les indications de la PPE selon l’état sérologique de la source et le mode de contamination éventuelle, la thérapie prophylactique de référence, le suivi sérologique de la personne exposée et enfin son nécessaire accompagnement psychologique.
Bibliographic references : Katz MH, Gerberding JL. Management of Occupational and Nonoccupational Postexposure HIV Prophylaxis. Curr Infect Dis Rep 2002 Dec;4(6):543-549
Weinberg GA. Postexposure prophylaxis against human immunodeficiency virus infection after sexual assault. Pediatr Infect Dis J 2002 Oct;21(10):959-60
Lirschhorn L, Kunches L, Mayer K. Nonoccupational postexposure prophylaxis: evolving clinical practice. AIDS Clin Care 2000 Jan;12(1):6-7, 9, 11-2
Eastham JH, Edwards KA, Godwin E. Factors influencing human immunodeficiency virus postexposure prophylaxis requests after low-risk occupational exposure. Mil Med 2002 Jun;167(6):506-9
Beltrami EM, Luo CC, de la Torre N, Cardo DM. Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen. Infect Control Hosp Epidemiol 2002 Jun;23(6):345-8
Braitstein P, Chan K, Beardsell A, McLeod A, Montaner JS, O'Shaughnessy MV, Hogg RS. Prescribing practices in a population-based HIV postexposure prophylaxis program. AIDS 2002 May 3;16(7):1067-70
Garb JR. One-year study of occupational human immunodeficiency virus postexposure prophylaxis. J Occup Environ Med 2002 Mar;44(3):265-70
Salgado CD, Flanagan HL, Haverstick DM, Farr BM. Low rate of false-positive results with use of a rapid HIV test. Infect Control Hosp Epidemiol 2002 Jun;23(6):335-7
Hosseinipour M, Cohen MS, Vernazza PL, Kashuba AD. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis 2002 May 15;34(10):1391-5
Stevens L, Brown MA. HIV postexposure prophylaxis after sexual assault. Nurse Pract Forum 2001 Dec;12(4):192-8
Mikulich VJ, Schriger DL; Abridged version of the updated US Public Health Service guidelines for the management of occupational exposures to hepatitis B virus, hepatitis C virus, and human immunodeficiency virus and recommendations for postexposure prophylaxis. Ann Emerg Med 2002 Mar;39(3):321-8
Preboth M; PHS guidelines for management of occupational exposure to HBV, HCV and HIV: HIV postexposure prophylaxis regimens. Am Fam Physician 2002 Jan 15;65(2):322, 324-5
Haiduven DJ. Planning a hepatitis C postexposure management program for health care workers. Issues and challenges. AAOHN J 2000 Aug;48(8):370-5
Roland ME, Martin JN, Grant RM, Hellmann NS, Bamberger JD, Katz MH, Chesney M, Franses K, Coates TJ, Kahn JO. Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure. J Infect Dis 2001 Dec 15;184(12):1608-12
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
